Notizie e Video - EVOTEC SEINH O.N.

Attualmente stai visualizzando tutte le notizie di borsa dello strumento finanziario EVOTEC SEINH O.N. in tutti i mercati in tutte le lingue.

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec SE kündigt erste Projekte für den LAB eN² Accelerator mit Novo Nordisk an • • EQS Group • Azioni

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec SE kündigt erste Projekte für den LAB eN² Accelerator mit Novo Nordisk an 11.12.2024 / 07:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Novo Nordisk und Evotec wählen drei Projekte von der Boston University, der Harvard University in Zusammenarbeit mit Mass General Brigham und dem Joslin Diabetes Center aus, die im Rahmen von LAB eN² entwickelt werden und sich auf kardiometabolische...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk • • EQS Group • Azioni

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec SE announces first projects for LAB eN² drug discovery accelerator with Novo Nordisk 11.12.2024 / 07:29 CET/CEST The issuer is solely responsible for the content of this announcement. Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases LAB eN² is also expanding,...

Grazie Grafico

> Notizie ACCESSWIRE ha pubblicato una nuova notizia.

Evotec SE announces first projects for LAB eN(2) drug discovery accelerator with Novo Nordisk • • ACCESSWIRE • Azioni

Novo Nordisk and Evotec select three projects from Boston University, Harvard University in collaboration with Mass General Brigham, and Joslin Diabetes Center to be developed within LAB eN² focusing on cardiometabolic diseases LAB eN² is also expanding, adding Boston Children's Hospital, Boston University, Johns Hopkins University, Joslin Diabetes Center, and the Icahn School of Medicine at Mount Sinai as new participating institutions HAMBURG, DE / ACCESSWIRE / December 11, 2024 / Evotec SE...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec announces change in Management Board • • EQS Group • Azioni

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec announces change in Management Board 29.11.2024 / 07:31 CET/CEST The issuer is solely responsible for the content of this announcement. Dr Craig Johnstone steps down as Chief Operating Officer effective 31 December 2024 Distribution of responsibilities internally Hamburg, Germany, 29 November 2024: Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec gibt Veränderung im Vorstand bekannt • • EQS Group • Azioni

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec gibt Veränderung im Vorstand bekannt 29.11.2024 / 07:31 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Dr. Craig Johnstone tritt mit Wirkung zum 31. Dezember 2024 als Chief Operating Officer zurück Verantwortlichkeiten werden intern verteilt Hamburg, 29 November 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) gab heute bekannt, dass ihr Chief...

Grazie Grafico

> Notizie ACCESSWIRE ha pubblicato una nuova notizia.

Evotec Announces Change in Management Board • • ACCESSWIRE • Azioni

Dr Craig Johnstone steps down as Chief OperatingOfficer effective 31 December 2024 Distribution of responsibilities internally HAMBURG, GERMANY / ACCESSWIRE / November 29, 2024 / Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) today announced that its Chief Operating Officer, Dr Craig Johnstone, will step down and leave the Company effective 31 December 2024. Dr Johnstone joined Evotec in May 2012 as SVP Drug Discovery and Innovation Efficiency and in...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-Adhoc: Kommentar zum Rückzug eines unverbindlichen Angebots • • EQS Group • Azioni

EQS-Ad-hoc: Evotec SE / Schlagwort(e): Sonstiges Kommentar zum Rückzug eines unverbindlichen Angebots 22.11.2024 / 16:55 CET/CEST Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Ad hoc: Kommentar zum Rückzug eines unverbindlichen Angebots Hamburg – Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-Adhoc: Comment on withdrawn non-binding offer • • EQS Group • Azioni

EQS-Ad-hoc: Evotec SE / Key word(s): Miscellaneous Comment on withdrawn non-binding offer 22-Nov-2024 / 16:55 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc: Comment on withdrawn non-binding offer Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9,...

Grazie Grafico

> Notizie ACCESSWIRE ha pubblicato una nuova notizia.

Comment on Withdrawn Non-Binding Offer • • ACCESSWIRE • Azioni

HAMBURG, GERMANY / ACCESSWIRE / November 22, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480)(NASDAQ:EVO) Evotec SE has taken notice of the statement made by Halozyme Therapeutics Inc. on 22 November, stating that it has withdrawn its non-binding proposal to acquire Evotec SE (NASDAQ:EVO) ("Evotec") for EUR11.00 per share in cash. The Management Board and Supervisory Board of Evotec, together with its advisors, have been in the...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-Adhoc: Kommentar zu Medienbericht • • EQS Group • Azioni

EQS-Ad-hoc: Evotec SE / Schlagwort(e): Sonstiges Kommentar zu Medienbericht 14.11.2024 / 22:51 CET/CEST Veröffentlichung einer Insiderinformation nach Artikel 17 der Verordnung (EU) Nr. 596/2014, übermittelt durch EQS News - ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Ad hoc: Kommentar zu Medienbericht Hamburg – Evotec SE (Frankfurter Wertpapierbörse: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ:...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-Adhoc: Comment on media report • • EQS Group • Azioni

EQS-Ad-hoc: Evotec SE / Key word(s): Miscellaneous Comment on media report 14-Nov-2024 / 22:51 CET/CEST Disclosure of an inside information acc. to Article 17 MAR of the Regulation (EU) No 596/2014, transmitted by EQS News - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement. Ad hoc: Comment on media report Hamburg, Germany – Evotec SE (Frankfurt Stock Exchange: EVT, SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480; NASDAQ: EVO) With...

Grazie Grafico

> Notizie ACCESSWIRE ha pubblicato una nuova notizia.

Comment on Media Report • • ACCESSWIRE • Azioni

HAMBURG, GERMANY / ACCESSWIRE / November 14, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT) (SDAX/TecDAX, Prime Standard, ISIN: DE 000 566480 9, WKN 566480 (NASDAQ:EVO) With respect to a media report, Evotec SE ("Company") declares that it has received, without prior contact, a non-binding expression of interest from the listed US biotechnology company Halozyme Therapeutics Inc. regarding a takeover offer addressed to the shareholders of the Company with an offer price of EUR 11.00 per share....

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec SE berichtet über die Ergebnisse der ersten neun Monate 2024: Strategische Fortschritte und erfolgreiche Expansion in einem schwierigen Marktumfeld • • EQS Group • Azioni

EQS-News: Evotec SE / Schlagwort(e): 9-Monatszahlen Evotec SE berichtet über die Ergebnisse der ersten neun Monate 2024: Strategische Fortschritte und erfolgreiche Expansion in einem schwierigen Marktumfeld 06.11.2024 / 07:00 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Prognose für 2024 bestätigt: Umsatzerlöse und bereinigtes EBITDA für das Gesamtjahr 2024 liegen im Plan, trotz herausfordernder Marktbedingungen Robustes Wachstum von Just – Evotec...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions • • EQS Group • Azioni

EQS-News: Evotec SE / Key word(s): 9 Month figures Evotec SE reports 9M 2024 results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions 06.11.2024 / 07:00 CET/CEST The issuer is solely responsible for the content of this announcement. Guidance for 2024 confirmed with full-year 2024 revenue and adjusted EBITDA targets on track, despite challenging market conditions Robust growth of Just - Evotec Biologics driven by roll out of projects together with Sandoz and...

Grazie Grafico

> Notizie ACCESSWIRE ha pubblicato una nuova notizia.

Evotec SE Reports 9M 2024 Results: Strategic Progress and Successful Expansion Amid Challenging Market Conditions • • ACCESSWIRE • Azioni

Guidance for 2024 confirmed with full-year 2024 revenue and adjusted EBITDA targets on track, despite challenging market conditions Robust growth of Just - Evotec Biologics driven by roll out of projects together with Sandoz and progress of discovery partnerships Successful extensions & expansions with BMS and Novo Nordisk; new collaboration with Pfizer to advance cutting-edge therapeutic solutions Priority reset on track to deliver annualised adj. EBITDA improvement of over € 40 m and...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec Announces Sale of API Manufacturing Facility to Monacum Partners • • EQS Group • Azioni

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec Announces Sale of API Manufacturing Facility to Monacum Partners 05.11.2024 / 07:29 CET/CEST The issuer is solely responsible for the content of this announcement. Evotec divests chemical API-focused CDMO operation in Halle/Westphalia (Evotec DS) to Monacum Partners Transaction aligns with Evotec’s strategic optimization efforts, concentrating resources on key growth drivers New ownership committed to maintaining and growing the business...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec gibt Verkauf von API-Produktionsanlage an Monacum Partners bekannt • • EQS Group • Azioni

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec gibt Verkauf von API-Produktionsanlage an Monacum Partners bekannt 05.11.2024 / 07:29 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Evotec veräußert auf API Herstellung fokussierten CDMO-Betrieb in Halle (Westf.) (Evotec DS) an Monacum Partners Transaktion ist Teil von Evotecs strategischer Optimierung, die eigenen Ressourcen auf Kernwachstumstreiber zu konzentrieren Neuer Eigentümer verpflichtet...

Grazie Grafico

> Notizie ACCESSWIRE ha pubblicato una nuova notizia.

Evotec Announces Sale of API Manufacturing Facility to Monacum Partners • • ACCESSWIRE • Azioni

Evotec divests chemical API-focused CDMO operation in Halle/Westphalia (Evotec DS) to Monacum Partners Transaction aligns with Evotec's strategic optimization efforts, concentrating resources on key growth drivers New ownership committed to maintaining and growing the business HAMBURG, GERMANY / ACCESSWIRE / November 5, 2024 / Evotec SE (Frankfurt Stock Exchange:EVT)(MDAX/TecDAX, ISIN: DE0005664809)(NASDAQ:EVO) has announced the sale of its chemical API manufacturing site, Evotec DS GmbH,...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec SE: Bekanntgabe der Ergebnisse für die ersten neun Monate 2024 am 06. November 2024 • • EQS Group • Azioni

EQS-News: Evotec SE / Schlagwort(e): Sonstiges Evotec SE: Bekanntgabe der Ergebnisse für die ersten neun Monate 2024 am 06. November 2024 30.10.2024 / 08:10 CET/CEST Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich. Hamburg, 30. Oktober 2024: Die Evotec SE (Frankfurter Wertpapierbörse: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) veröffentlicht am Mittwoch, 06. November 2024, ihren Bericht für die ersten neun Monate 2024. In einer Telefonkonferenz in...

Grazie Grafico

> Notizie EQS Group ha pubblicato una nuova notizia.

EQS-News: Evotec SE to announce results for the first nine months 2024 on 06 November 2024 • • EQS Group • Azioni

EQS-News: Evotec SE / Key word(s): Miscellaneous Evotec SE to announce results for the first nine months 2024 on 06 November 2024 30.10.2024 / 08:10 CET/CEST The issuer is solely responsible for the content of this announcement. Hamburg, Germany, 30 October 2024: Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) will announce its financial results for the first nine months of 2024 on Wednesday, 06 November 2024. The Company is going to hold a conference call...

Grazie Grafico